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and other exanthem-inducing agents: cytomegalovirus, EpsteineBarr virus, human herpesviruses-6, -7, and -8, and parvovirus B19 [PVB19]). Fourteen cases with serology suggestive of recent enteroviral infection were selected.
Ten of the 14 cases had enterovirus RNA in plasma: sequencing identified the infecting pathogen as CV-A6. Cases 1 and 10 were also positive for PVB19. Cytomegalovirus, EpsteineBarr virus, and human herpesviruses-6, -7, and -8 could not be detected.
Investigated cases were: typical HFMD (1 case; petechial adult maculopapules or vesicles on the extensor surfaces of hands, feet, and oral mucosa), atypical HFMD (5 cases; absence of involvement of 1 typical site or involvement of adjacent sites, such as the face, scalp, and ankles), and atypical exanthems (4 cases; maculopapular eruption over the whole body). As seen in Table I , 9 cases had oral papulovesicles or petechiae, 5 cases had cutaneous erythematovesicles (on the hands and feet), 4 cases had maculopapules with petechiae, and 3 cases had erythematous papules on the trunk. Other affected body sites included the face, scalp, elbows, legs, and buttocks. Lesions were reported as burning/itchy. Two patients presenting with maculopapules on the buttocks were coinfected with PVB19. Cases 3 and 6 developed early complications-orchiepididymitis and onychomadesis, respectively. On average, clinical resolution occurred in 12 days.
The 10 patients were followed-up for 2 years. Clinical examinations highlighted conditions that may be considered sequelae of the initial infection (Table I) : case 3 developed degenerative mitral valve disease and maintained low-level CV-A6 viremia, indicating that the virus had established low-level persistence in the host; cases 2, 8, and 10 developed persistent myalgia/arthralgia. Notably, case 2 (negative at the onset for antinuclear antibodies, antineutrophil cytoplasmic antibodies, and rheumatoid factor antibodies) developed symmetric polyarthritis with rheumatoid factor positivity and antibodies to cyclic citrullinated peptides. PVB19 was not detected in any cases.
The variable clinical expression at onset 3 and the development of changeable longstanding sequelae in patients infected by the same virus type could be linked to the unpredictable expression pattern of the multiple EV receptor types in different subjects. 4, 5 In closing, severe atypical HFMD may be followed by long-term sequelae. It is therefore important to recognize different HFMD forms and to obtain detailed virology reports. It is also important to use long-term follow-up programs to uncover the possible longstanding sequelae of this condition that is emerging in adults. 
Prognostic value of the Breslow:diameter ratio in cutaneous melanoma
To the Editor: The most frequently used staging system in melanoma is based on the TNM classification, which includes the variables for tumor thickness, lymphatic spreading, and the presence of distant metastasis and ulceration. The thickness of the primary tumor is assessed by the Breslow index, which influences the T stage; an increase in the Breslow index is directly associated with a decrease in overall survival and is the most decisive factor in this regard. 1, 2 The diameter of a melanoma is not always related to its increase in depth, which brings into question whether a proportion that takes into 
